臨床試驗

Controlling Amyotrophic Lateral Sclerosis Motor Neuron Excitability Study

NCT：NCT06649955 · RECRUITING

NCT IDNCT06649955

狀態RECRUITING

開始日期2025-02-10

SponsorPathMaker Neurosystems Inc. (INDUSTRY)

First posted2024-10-21

Last updated2026-09-10

簡要摘要

Following completion of the ALS Early Feasibility Study of the MyoRegulator® device for treatment of ALS (NCT06165172), the CALM study will further assess the feasibility of the MyoRegulator® device to treat ALS in an expanded number of individuals with ALS. CALM will gather additional preliminary evidence of clinical safety and potential effectiveness in this patient population with a longer follow-up period and additional secondary endpoints in a single-arm study prior to commencing a larger sham-controlled pivotal trial.

官方來源

在 ClinicalTrials.gov 上查看 →

資料來自 ClinicalTrials.gov API。最新狀態請參閱官方紀錄。